PROMOTION APRILINE® HA FILLERS LIQUID FACELIFT WITH
Nikolaus Linde and Natalia Mikhailova describe why the Apriline range of dermal fillers are the perfect choice to restore volume to an ageing face
fatigue, along with habitual facial expressions result in the so-called hyperdynamic wrinkles and folds.
NIKOLAUS LINDE, MD is Founder of NL Dr. Nikolaus Linde Clinics in
St.Gallen and Zurich, Switzerland. President of the Swiss Academy of Cosmetic Surgery
NATALIA MIKHAILOVA, MD, is Dermatovenerologist, Chief Physician of Reform Clinic; President of the National Mesotherapy Society, Russia
S 56
Injections: dermal fillers Facelifts are a procedure aimed at the restoration of the contours of a young face by means of skin tightening. It can be achieved either by removal of excessive atonic skin (surgery) or by repositioning sagging tissue (aesthetic treatments). Injectable facelift involves botulinum toxin injections and the introduction of volumizing dermal fillers. This article will primarily touch upon dermal fillers. The hyaluronic acid (HA) fillers provide
URGICAL APPROACHES TO
the correction of facial ageing have changed dramatically over the last few decades. A range of injection techniques have now gained wide acceptance, in
some cases, these methods have replaced surgical invasion. Injection techniques can not only improve the appearance and texture of the skin and eliminate wrinkles, they also reduce the risk of complications, shorten recovery periods and reduce costs.
Facial ageing The process of facial ageing mostly occurs under the influence of external and internal factors. These factors include the impact of sun exposure, smoking, nutrition, alcohol consumption and health changes. The gravitational ptosis of soft tissues, reduced amount of fat and involutional changes in the soft tissues and bones exacerbate the above- mentioned process. Additionally, muscle
support for facial tissues. Today’s market offers a wide range of HA fillers with different viscosity, elasticity and duration of the desired effect. These products are extremely safe and provide long-lasting results. The APRILINE® range (Suisselle, Switzerland) of HA filler products are monophasic, homogeneous, sterile apyrogenic gels with high plasticity and a 23 mg/ml concentration of HA. APRILINE® contains biosynthetic hyaluronic acid modified in accordance with A.P.R.I. technology. The reticulation of the hyaluronic acid in APRILINE® NORMAL filler is 9% while the reticulation of the HA in APRILINE® FORTE filler is 14%.
Volumizing A volumizing facelift is designed to restore a young face by means of injecting HA fillers. Injectable facelift is primarily achieved by volumizing the malar area and mandibular angle. Recovery of the missing volume in the above-mentioned areas provides necessary support for SMAS and thus leads to the relocation of sagging soft tissue to its original position. The product used for this purpose has to possess the following:
January/February 2016 |
prime-journal.com
A long biodegradation period, 10–12 months (hyaluronic acid administered subcutaneously degrades faster than intradermally injected HA)
High plasticity (which helps to determine the required contour)
Quality formative effect with high viscosity (ability to ‘hold’ reference points). APRILINE® FORTE meets all these
requirements.
Restoring malar area volume APRILINE® FORTE, being the densest product, is used to restore malar area volume. Before using a cannula, one has to perform markings according to Hinderer (Figure 1A), or according to Swift (Figure 1B) and define the area of soft tissue deficiency. The next step is to make a foramen (the middle of the zygomatic outgrowth of the temporal bone). The product is to be injected under the circular muscle of the eye with a cannula in a linear retrograde way in SOOF lifts. One has to insert the cannula perpendicularly all the way to the bone. After that, while twisting the cannula one has to insert it along with the given vectors parallel to the skin surface. It is possible to apply a bolus injection at an
apex point in order to create face relief and emphasize malar eminence. Moving the soft tissues of the zygomatic area against the ptosis vector provides the reduction of furrows (tear and velar) and smoothing of the nasolabial fold while balancing the face oval. When using a needle in the zygomatic area, the product must be administered slowly (0.1 ml over 10–15 seconds). This reduces the pain caused by the tissue distension. Mandibular corners become the reference
point for the lower-face facelift. Due to the age- related bone resorption, the angles are smoothed, resulting in a ‘slipping’ of the soft
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68